Nisa Investment Advisors, LLC Allogene Therapeutics, Inc. Transaction History
Nisa Investment Advisors, LLC
- $15.7 Billion
- Q2 2024
A detailed history of Nisa Investment Advisors, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 10,767 shares of ALLO stock, worth $30,470. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,767
Previous 2,033
429.61%
Holding current value
$30,470
Previous $9,000
177.78%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ALLO
# of Institutions
163Shares Held
106MCall Options Held
97.5KPut Options Held
45.6K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$53 Million1.76% of portfolio
-
Black Rock Inc. New York, NY9.65MShares$27.3 Million0.0% of portfolio
-
State Street Corp Boston, MA9.18MShares$26 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.21MShares$23.2 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA5.45MShares$15.4 Million0.02% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $407M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...